000			01209 a2200349 4500
005			20250514205606.0
264		0	_c20041109
008			200411s 0 0 heb d
022			_a0792-9935
040			_aNLM _beng _cNLM
100	1		_aAframian, D J
245	0	0	_a[Future therapy strategies for salivary gland impairment]. _h[electronic resource]
260			_bRefu'at ha-peh veha-shinayim (1993) _cJul 2004
300			_a43-50, 93 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAmifostine _xtherapeutic use
650	0	4	_aCranial Irradiation _xadverse effects
650	0	4	_aHead and Neck Neoplasms _xradiotherapy
650	0	4	_aHumans
650	0	4	_aMuscarinic Agonists _xtherapeutic use
650	0	4	_aPilocarpine _xtherapeutic use
650	0	4	_aQuinuclidines _xtherapeutic use
650	0	4	_aRadiation Injuries _xdrug therapy
650	0	4	_aRadiation-Protective Agents _xtherapeutic use
650	0	4	_aRegeneration
650	0	4	_aSaliva _xmetabolism
650	0	4	_aSalivary Glands _xradiation effects
650	0	4	_aThiophenes
700	1		_aPalmon, A
700	1		_aNahlieli, O
773	0		_tRefu'at ha-peh veha-shinayim (1993) _gvol. 21 _gno. 3 _gp. 43-50, 93
999			_c15193063 _d15193063